Item 5. Market for Registrant’s Common Equity
Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
Common Stock
Our common stock is traded on the New York Stock Exchange under the symbol “AROC.” On February 18, 2026, the closing price of our common stock on the New York Stock Exchange was $32.90 per share.
40
Table of Contents
Comparison of Five Year Cumulative Total Return
The performance graph below shows the cumulative total stockholder return on our common stock compared with the S&P 500, AMNAX and AMZ indices over the five–year period beginning on December 31, 2020. The results are based on an investment of $100 in each of our common stock, the S&P 500, the AMNAX and the AMZ. The graph assumes reinvestment of dividends and adjusts all closing prices and dividends for stock splits.
The performance graph shall not be deemed incorporated by reference by any general statement incorporating by reference this Form 10–K into any filing under the Securities Act or the Securities Exchange Act, except to the extent that we specifically incorporate this information by reference, and shall not otherwise be deemed filed under those Acts.
Holders
As of February 18, 2026, there were approximately 1,100 holders of record of our common stock. The actual number of stockholders is greater than this number of record holders and includes stockholders who are beneficial owners but whose shares are held in street name by banks, brokers and other nominees.
Dividends
On January 29, 2026, our Board of Directors declared a quarterly dividend of $0.22 per share of common stock, or approximately $38.7 million, which was paid on February 18, 2026 to stockholders of record at the close of business on February 10, 2026. Any future determinations to pay cash dividends to our stockholders will be at the discretion of our Board of Directors and will be dependent upon our financial condition, results of operations, credit and loan agreements in effect at that time and other factors deemed relevant by our Board of Directors. We cannot provide assurance that we will declare or pay dividends in any particular amount or at all in the future.
Securities Authorized for Issuance under Equity Compensation Plans
For disclosures regarding securities authorized for issuance under equity compensation plans, see Part III, Item 12. “Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters” of this Form 10–K.
41
Table of Contents
Unregistered Sales of Equity Securities and Use of Proceeds
None.
Purchases of Equity Securities by Issuer and Affiliated Purchasers
The following table summarizes our purchases of equity securities during the three months ended December 31, 2025:
Total number of
Approximate dollar
Average
shares repurchased
value of shares
price
as part of publicly
that may yet be
Total number
paid per
announced plans
purchased under the
(dollars in thousands, except per share amounts)
of shares purchased (1)
share (2)
or programs (3)
plans or programs (3)
October 1, 2025 — October 31, 2025
128,330
$
23.96
128,330
$
130,403
November 1, 2025 — November 30, 2025
294,458
23.58
294,150
123,467
December 1, 2025 — December 31, 2025
225,000
25.83
225,000
117,655
Total
647,788
$
24.44
647,480
(1) Represents shares of common stock purchased from employees to satisfy tax withholding obligations in connection with the vesting of restricted stock awards and shares repurchased under the Share Repurchase Program during the period. See Note 17 (“Stockholders’ Equity”) for further details.
(2) Average price paid per share includes costs associated with the repurchase, as applicable.
(3) Our Board of Directors authorized the Share Repurchase Program in April 2023, which allowed us to repurchase and retire up to $50.0 million of outstanding common stock. Between April 2024 and October 2025, extensions of the Share Repurchase Program were approved by our Board of Directors, authorizing an additional $200.0 million, or a total of $250.0 million, to repurchase and retire outstanding common stock through D ecember 31, 2026 . See Note 17 (“Stockholders’ Equity”) for further details .
Item 6. [Reserved]